Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 801–900 of 1,000
Vilahur, G., Oñate, B., Cubedo, J., Béjar, M. T., Arderiu, G., Peña, E., Casaní, L., Gutiérrez, M., Capdevila, A., Pons‐Lladó, G., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0509-2 · Cited by 30
“Besides angiogenesis, ASCs have been shown to exert anti-inflammatory and anti-apoptotic properties eventually favoring the cardiac healing process [20].”
BackgroundFatma, S., Selby, D. E., Singla, R. D., & Singla, D. K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3104 · Cited by 29
“myocardium is mediated through autocrine or paracrine action following cells transplantation (7, 8, 30, 31).”
InfluentialDissecting Paracrine Effectors for Mesenchymal Stem Cells
Bruno, S., Collino, F., Tetta, C., & Camussi, G. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_149 · Cited by 31
Regmi, S., Pathak, S., Thanh, T. P., Nguyen, T. T., Sung, J., Yook, S., Kim, J. O., Yong, C. S., Choi, I., Doh, K., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1337-3 · Cited by 29
Li, H., Hu, D., Chen, G., Zheng, D., Li, S., Lin, Y., Hong, H., Luo, Y., Ke, Y., Huang, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03610-1 · Cited by 29
Extracellular vesicles in cardiac repair and regeneration: Beyond stem-cell-based approaches
Femminò, S., Bonelli, F., & Brizzi, M. F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.996887 · Cited by 30
Giannasi, C., Morte, E. D., Cadelano, F., Valenza, A., Casati, S., Dei, M., Niada, S., & Brini, A. T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115970 · Cited by 30
“Gnecchi et al., who described marked myocardial protection by MSC-secreted factors in a rat experimental model of coronary occlusion [5].”
Antioxidants Improve Early Survival of Cardiomyoblasts After Transplantation to the Myocardium
Rodriguez-Porcel, M. G., Gheysens, O. S., Paulmurugan, R., Chen, I. Y., Peterson, K. M., Willmann, J. K., Wu, J. C., Zhu, X., Lerman, L. O., & Gambhir, S. S. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0274-4 · Cited by 29
“role in the substantial cell death observed after transplantation [9, 10].”
BackgroundKim, S.-W., Kim, S., & Yoon, Y. (2011) · Regenerative Medicine · doi:10.2217/rme.11.24 · Cited by 29
Wáng, Y. X. J., Quercy-Jouvet, T., Wang, H., Li, A.-W., Chak, C., Xuan, S., Shi, L., Wang, D., Lee, S., Leung, P., et al. (2011) · Materials · doi:10.3390/ma4040703 · Cited by 29
“Transfecting agents are highly charged macromolecules that have been used to transfect oligonucleotides into cells via electrostatic interaction, which result in endosome formation [26-29].”
BackgroundTaking a bite out of spinal cord injury: do dental stem cells have the teeth for it?
Bianco, J. I., Berdt, P. D., Deumens, R., & Rieux, A. D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2126-5 · Cited by 30
“The potential of human BMSCs in treating ischemia has already been highlighted, and is thought to be through secretion of paracrine cytoprotective factors [221].”
BackgroundEfficiency of Exosome Production Correlates Inversely with the Developmental Maturity of MSC Donor
Yeo, R. W. Y. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000145 · Cited by 32
“Volume 3 • Issue 3 • 1000145 J Stem Cell Res Ther ISSN:2157-7633 JSCRT, an open access journal MSC secretion as the therapeutic agent has been proposed [65-73].”
BackgroundRaval, A. N., Cook, T. D., Duckers, H. J., Johnston, P. V., Traverse, J. H., Abraham, W. T., Altman, P. A., & Pepine, C. J. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.016 · Cited by 29
Khorramirouz, R., Kameli, S. M., Fendereski, K., Daryabari, S. S., & Kajbafzadeh, A. M. (2019) · Regenerative Medicine · doi:10.2217/rme-2018-0024 · Cited by 30
Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction
Park, T. Y., Oh, J., Cho, J. S., Sim, S. B., Lee, J.-H., & Chi, H. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.047 · Cited by 29
Mesenchymal stem cell-derived extracellular vesicles in the failing heart: past, present, and future
Karbasiafshar, C., Sellke, F. W., & Abid, M. R. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00951.2020 · Cited by 30
Wang, Y., Wang, M., Abarbanell, A. M., Weil, B. R., Herrmann, J. L., Tan, J., Novotny, N. M., Coffey, A. C., & Meldrum, D. R. (2009) · Surgery · doi:10.1016/j.surg.2009.04.013 · Cited by 29
Cell therapy for acute myocardial infarction
Wollert, K. C. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.011 · Cited by 35
Yu, X.-Y., Geng, Y., Li, X. H., Lin, Q. X., Shan, Z., Lin, S. G., Song, Y. H., & Li, Y. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0170-x · Cited by 29
“ficial effects of stem cells are mediated by paracrine factors produced by MSCs [14, 15].”
BackgroundExosomes in Cardiovascular Medicine
Dykes, I. M. (2017) · Cardiology and Therapy · doi:10.1007/s40119-017-0091-9 · Cited by 29
Poynter, J. A., Manukyan, M. C., Wang, Y., Brewster, B. D., Herrmann, J. L., Weil, B. R., Abarbanell, A. M., & Meldrum, D. R. (2011) · Surgery · doi:10.1016/j.surg.2011.06.006 · Cited by 37
Fang, J., Chen, L., Fan, L., Wu, L., Chen, X., Li, W., Lin, Y., & Wang, W. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.013 · Cited by 28
“The pretreatment of donor cells with hypoxic stimulus, growth factors, or anti-apoptotic and pro-survival genetic modification produces a temporally indeterminate result, or even poses a tumorigenic risk [4,13,24,25].”
BackgroundThe Evolution of the Stem Cell Theory for Heart Failure
Silvestre, J., & Menasché, P. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.010 · Cited by 28
“Human and murine bone marrow-derived mesenchymal stem cells also release a broad range of factors with proangiogenic capacities including growth factors (VEGF, FGF-2, FGF-7, insulin growth factor (IGF), platelet-derived growth factor, placenta growth factor metalloproteases (MMP-1, MMP-2, MMP- 9, t-PA) and factors inv…”
BackgroundMitochondrial donation in translational medicine; from imagination to reality
Bagheri, H. S., Bani, F., Taşoğlu, S., Zarebkohan, A., Rahbarghazi, R., & Sokullu, E. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02529-z · Cited by 30
“Commensurate with these comments, a plethora of documents have shown that paracrine activity and regulation of inflammatory responses are the main underlying mechanisms driven by MSCs rather than in situ proliferation and differentiation toward cardiomyocyte-like cells [128].”
New treatment methods for myocardial infarction
Sun, B., Wang, L., Guo, W., Chen, S., Ma, Y., & Wang, D. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1251669 · Cited by 31
Yang, J., Zhang, H., Zhao, L., Chen, Y., Liu, H., & Zhang, T. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2829 · Cited by 31
“This protection can be further strengthened when pretreatment was performed to implanted cells, such as gene modification or cytokine treatment.(4,5) These phenomena revealed shining prospects of stem cell implantation in coronary heart disease and underline the important mechanisms of heart function improvement, angi…”
BackgroundBone marrow cell transfer in acute myocardial infarction
Janssens, S. P., Theunissen, K., Boogaerts, M., & de Werf, F. V. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0440 · Cited by 28
“Whether genetically modified cells, which are better protected against apoptotic cell death”
BackgroundTrophic Actions of Bone Marrow-Derived Mesenchymal Stromal Cells for Muscle Repair/Regeneration
Sassoli, C., Zecchi‐Orlandini, S., & Formigli, L. (2012) · Cells · doi:10.3390/cells1040832 · Cited by 34
Autologous cell therapy for cardiac repair
Davis, D. R., & Stewart, D. J. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.556615 · Cited by 34
Gouadon, E., Moore‐Morris, T., Smit, N. W., Chatenoud, L., Coronel, R., Harding, S. E., Jourdon, P., Lambert, V., Rücker‐Martin, C., & Pucéat, M. (2015) · Stem Cells · doi:10.1002/stem.2205 · Cited by 28
Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
Ellison, G. M., & Madeddu, P. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.007 · Cited by 29
“The stem cell secretome supports cardiomyocyte survival and proliferation, differentiation of resident stem cells, and neovascularization, while limiting inflammatory and pro-fibrotic processes (Baraniak &McDevitt, 2010; Gnecchi et al., 2005; Rao et al., 2015; Zhou et al., 2011).”
BackgroundWu, M., Ji, S., Xiao, S., Kong, Z., He, F., Zhang, Y., Ji, K., Zheng, Y., Liu, H., & Xia, Z. (2015) · Clinical Science · doi:10.1042/cs20140735 · Cited by 28
Lilyanna, S., Martinez, E. C., Vu, T. D., Ling, L. H., Gan, S. U., Tan, A. L., Phan, T. T., & Kofidis, T. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0407 · Cited by 28
“It seems that these paracrine mediators are expressed or released in a temporal and spatial manner exerting different effects depending on local tissue factors after injury.(6) Upregulation of multiple paracrine factors, such as angiogenic cytokines (VEGF-A, HGF, bFGF, angiopoietin-1 and - 2, and PDGF-B), cardiac tran…”
Zhao, T. C., Tseng, A., Yano, N., Tseng, Y., Davol, P. A., Lee, R. J., Lum, L. G., & Padbury, J. F. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01109.2007 · Cited by 32
“This may be due to paracrine secretory effects of stem cells, which have been regarded as important mechanisms whereby stem cells generate these protective effects (7).”
BackgroundYeghiazarians, Y., Honbo, N. Y., Imhof, I., Woods, B. J., Aguilera, V., Ye, J., Boyle, A., & Karliner, J. S. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000061 · Cited by 28
Taghavi, S., Sharp, T. E., Duran, J. M., Makarewich, C. A., Berretta, R. M., Starosta, T., Kubo, H., Barbe, M. F., & Houser, S. R. (2015) · Clinical and Translational Science · doi:10.1111/cts.12251 · Cited by 28
Cell-Based Therapies for Lung Vascular Diseases: Lessons for the Future
Stewart, D. J., & Mei, S. H. J. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201105-035mw · Cited by 27
Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration
Schaun, M. I., Eibel, B., Kristocheck, M., Sausen, G., Machado, L. R. G., Koche, A., & Markoski, M. M. (2016) · Stem Cells International · doi:10.1155/2016/2171035 · Cited by 30
“In this context, humoral and paracrine factors released from stem cells and progenitor cells can improve cardiac function by reducing the apoptosis of cardiomyocytes or by activating CSC to increase cardiomyogenesis [70].”
Stem cell-derived exosomes as a cell free therapy against spinal cord injury
Khalatbary, A. R. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101559 · Cited by 27
Extracellular Vesicle-Based Therapeutics in Neurological Disorders
Yuan, Y., Sun, J., You, T., Shen, W., Xu, W., Dong, Q., & Cui, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122652 · Cited by 29
“proposed that paracrine factors account for the protective effects of MSCs [32].”
BackgroundXu, H., Fu, J., Chen, L., Zhou, S., Fang, Y., Zhang, Q., Chen, X., Li, Y., Li, Y., Xu, Z., et al. (2023) · Stem Cells International · doi:10.1155/2023/2988907 · Cited by 28
Evaluation of neural plasticity in adult stem cells
Ross, J. J., & Verfaillie, C. M. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.2021 · Cited by 30
Cellular Therapy for Heart Failure
Psaltis, P. J., Schwarz, N., Toledo‐Flores, D., & Nicholls, S. J. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160606121858 · Cited by 31
“Paracrine interactions have been shown to bring about myocardial restoration and repair through a diverse array of salutary processes that consist of: (1) activation of the proliferation and differentiation of endogenous cardiac progenitor cells [93, 101, 115]; (2) stimulation of neovascularization by the release of c…”
BackgroundChen, X., Lu, M., Ma, N., Yin, G., Cui, C., & Zhao, S. (2016) · Stem Cells International · doi:10.1155/2016/4656539 · Cited by 27
“We speculated that secretion of certain cytokines might contribute to the paracrine effects, which potentially plays a critical role in the therapeutic effects on the infarcted hearts rather than transdifferentiation in this case [38, 39].”
BackgroundStem Cell Therapy for the Heart: Blind Alley or Magic Bullet?
Bruyneel, A. A. N., Sehgal, A., Malandraki-Miller, S., & Carr, C. A. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9708-y · Cited by 27
“Overexpression of Akt in transplanted MSCs improved their posttransplantation viability and therapeutic efficacy, leading to improved LV function by paracrine protection of the cardiomyocytes [110].”
BackgroundBittle, G. J., Morales, D., Pietris, N., Parchment, N., Parsell, D., Peck, K., Deatrick, K., Rodríguez-Borlado, L., Smith, R., Marban, L., et al. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.06.154 · Cited by 20
Repairing damaged myocardium: Evaluating cells used for cardiac regeneration
Schuldt, A. J. T., Rosen, M. R., Gaudette, G. R., & Cohen, I. S. (2008) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-008-0007-z · Cited by 27
Lian, W., Cheng, W. T., Cheng, C.-C., Hsiao, F. S., Cheng, C., Cheng, C., & Wu, S. (2011) · Life Sciences · doi:10.1016/j.lfs.2010.12.020 · Cited by 27
“An engineered AKT gene was introduced to the MSCs to increase the cell survival rate via AKT's anti-oxidative stress effects (Gnecchi et al., 2005, 2006, 2009).”
MethodSolheim, S., Seljeflot, I., Lunde, K. B., Aukrust, P., Yndestad, A., Grøgaard, H. K., Aakhus, S., Forfang, K., & Arnesen, H. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.10.005 · Cited by 29
Cell‐Based Approaches for Cardiac Repair
Rubart, M., & Field, L. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1380.004 · Cited by 27
Golgi-restored vesicular replenishment retards bone aging and empowers aging bone regeneration
Liu, P., Guo, H., Huang, X., Liu, A., Zhu, T., Zheng, C., Fu, F., Zhang, K., Li, S., Luo, X., et al. (2025) · Bone Research · doi:10.1038/s41413-024-00386-w · Cited by 28
Yuen, D. A., Connelly, K. A., Zhang, Y., Advani, S. L., Thai, K., Kabir, G., Kepecs, D. M., Spring, C. M., Smith, C. R., Batruch, I., et al. (2013) · Stem Cells · doi:10.1002/stem.1502 · Cited by 26
“Indeed, recent opinion favors a paracrine mechanism of action whereby the administered cells secrete a range of factors that initiate endogenous regenerative programs by cells in their immediate proximity [9].”
Chen, C.-Y., Tsai, C.-H., Chen, C.-Y., Wu, Y.-H., & Chen, C. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1108510 · Cited by 27
“Mesenchymal stem cells have been reported to cooperate with endothelial cells to enhance and stabilize vascular network formation(24,25) through secreting angiogenic growth factors with or without the need of a direct cell to cell contact.(26,27) We previously showed that hPMSCs have a phenotype similar to that of bon…”
BackgroundIsolation and characterization of mesenchymal stem cells from human fetus heart
Garikipati, V. N. S., Singh, S. P., Mohanram, Y., Gupta, A., Kapoor, D., & Nityanand, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192244 · Cited by 26
Mesenchymal stem cells to treat liver diseases
Eom, Y. W., Kang, S. H., Kim, M. Y., Lee, J. I., & Baik, S. K. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.163 · Cited by 29
“Paracrine action is one of the key mechanisms that can be evaluated to explore the therapeutic potential of MSCs (94,95).”
BackgroundHoecke, L. V., Cauwenberghe, C. V., Börger, V., Bruggeman, A., Castelein, J., Imschoot, G. V., Wonterghem, E. V., Dittrich, R., Claeys, W., Xie, J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121864 · Cited by 30
Stem cell stimulation of endogenous myocyte regeneration
Weil, B. R., & Canty, J. M. (2013) · Clinical Science · doi:10.1042/cs20120641 · Cited by 26
Multimarker approach for heart failure management: Perspectives and limitations
Giannessi, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.006 · Cited by 27
“Although it is more difficult to use this strategy with a heart with a global dysfunction, recent data suggest that the efficacy of cell-based therapy may be due to paracrine effects of injected cells on endogenous cells [62], thus indicating the induction of such paracrine effects as a novel therapeutic target.”
BackgroundSekiya, N., Tobita, K., Beckman, S., Okada, M., Gharaibeh, B., Sawa, Y., Kormos, R. L., & Huard, J. (2013) · Molecular Therapy · doi:10.1038/mt.2012.266 · Cited by 26
Chang, S.-A., Kim, H.-K., Lee, H.-Y., Choi, S.-Y., Koo, B., Kim, Y., Dw, S., Oh, B., Yb, P., Choi, Y., et al. (2007) · Heart · doi:10.1136/hrt.2007.124701 · Cited by 26
Kemp, K. C., Mallam, E., Hares, K. M., Witherick, J., Scolding, N. J., & Wilkins, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026098 · Cited by 32
“Increasing evidence suggests a major protective role of MSCs is their capacity to secrete a diverse range of potentially trophic, paracrine and protective factors, in addition to anti -oxidant actions, thereby promoting an environment conducive to cellular protection and support diseased cell survival[15]–[20], [51],…”
BackgroundCancedda, R., Bollini, S., Descalzi, F., Mastrogiacomo, M., & Tasso, R. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00028 · Cited by 29
“, 2013), was exploited in a variety of preclinical models, among the others the myocardial infarction, the hind-limb ischemia, and the acute renal failure (Heederik et al., 1992; Gnecchi et al., 2005; Tögel et al., 2005).”
BackgroundHuang, D., Yin, L., Liu, X., Lv, B., Xie, Z., Wang, X., Yu, B., & Zhang, Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3276 · Cited by 26
“Due to the importance of the PI3K/Akt pathway on classical survival signals (26), the present study aimed to determine the association between geraniin and the PI3K/Akt pathway in MSCs. Cells were treated with geraniin (20 µM) for the indicated periods of time; the protein expression levels of…”
BackgroundBeez, C. M., Haag, M., Klein, O., Linthout, S. V., Sittinger, M., & Seifert, M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0504-0 · Cited by 26
Kanda, P., Benavente‐Babace, A., Parent, S., Michie, C., Soucy, N., Steeves, A. J., Lu, A., Cober, N. D., Courtman, D. W., Variola, F., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120010 · Cited by 26
Clinical-based Cell Therapies for Heart Disease—Current and Future State
Turner, D., Rieger, A. C., Balkan, W., & Hare, J. M. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10401 · Cited by 26
Bao, C., Guo, J., Zheng, M., Chen, Y., Lin, G., & Hu, M. (2010) · Biochemistry and Cell Biology · doi:10.1139/o10-018 · Cited by 27
“Gnecchi and his colleagues also revealed that AKt-modified MSCs tend to increase stem cell viability and induce paracrine effects on adjacent myocardium (Gnecchi et al. 2005).”
BackgroundWang, H., Zhao, T., Xu, F., Li, Y., Wu, M., Zhu, D., Cong, X., & Liu, Y.-J. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.07.011 · Cited by 27
Belmadani, S., Matrougui, K., Kolz, C. L., Pung, Y. F., Palen, D. I., Prockop, D. J., & Chilian, W. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186189 · Cited by 26
Haneef, K., Ali, A., Khan, I., Naeem, N., Jamall, S., & Salim, A. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12479 · Cited by 27
Regenerative medicine for the treatment of heart disease
Hansson, E. M., & Lendahl, U. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12033 · Cited by 29
Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
Park, M., & Yoon, Y. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0312 · Cited by 27
Wei, X., Zheng, W., Tian, P., Liu, H., He, Y., Peng, M., Liu, X., & Li, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15675 · Cited by 25
Yu, T., Xu, Q., Chen, X., Deng, X., Chen, N., Kou, M. T., Huang, Y., Guo, J., Xiao, Z., & Wang, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100957 · Cited by 30
“Amongst the various stem cell types used in post-MI cell therapy, mesenchymal stromal cells (MSCs) have gained attention due to their cardioprotective effects mediated by their secretion [83].”
BackgroundREVIEW: Stem Cell Therapy in Cardiovascular Disorders
Krause, K., Schneider, C., Kück, K., & Jaquet, K. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00208.x · Cited by 27
“In summary, paracrine and angiogenic effects play a major role for cardioprotective effects of non-ESC as described in other studies [40,48,107,115,116].”
BackgroundResultInfluentialDrummond, C. A., Sayed, M., Evans, K. L., Shi, H., Wang, X., Haller, S. T., Liu, J., Cooper, C. J., Xie, Z., Shapiro, J. I., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00102.2014 · Cited by 28
“However, hypoxic stress (28) and activation of the Akt pathway (15, 16) have been reported to increase SCF expression and secretion in mesenchymal stem cells.”
BackgroundThe art of cobbling a running pump—Will human embryonic stem cells mend broken hearts?
Zweigerdt, R. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.09.014 · Cited by 26
Remuscularizing Failing Hearts with Tissue Engineered Myocardium
Zimmermann, W. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2467 · Cited by 26
Non-invasive In-Vivo Imaging of Stem Cells after Transplantation in Cardiovascular Tissue
Mathiasen, A. B., & Kastrup, J. (2013) · Theranostics · doi:10.7150/thno.5787 · Cited by 26
“Presently, most research indicates that that the improvements are achieved through a paracrine effect [58].”
Ge, Y., Zhang, Q., Li, H., Bai, G., Jiao, Z., & Wang, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34939-x · Cited by 25
Nishikawa, T., Maeda, K., Nakamura, M., Yamamura, T., Sawada, T., Mizutani, Y., Ito, T., Ishikawa, T., Furukawa, K., Ohno, E., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06359-3 · Cited by 25
“As such, additional studies on the usefulness of administration of MSC-conditioned medium containing various factors, including anti-inflammatory cytokines and growth factors, have been reported as a new MSC therapy [20, 21].”
BackgroundStem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine
Roshanbinfar, K., Esser, T. U., & Engel, F. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8193 · Cited by 25
Stem cell‐based therapies for cardiac diseases: The critical role of angiogenic exosomes
Ghodrat, S., Hoseini, S. J., Asadpour, S., Nazarnezhad, S., Eghtedar, F. A., & Kargozar, S. (2021) · BioFactors · doi:10.1002/biof.1717 · Cited by 27
Mesenchymal Stem Cells for Treatment of Myocardial Infarction
Ko, I.-K., & Kim, B. (2008) · International Journal of Stem Cells · doi:10.15283/ijsc.2008.1.1.49 · Cited by 25
“An animal study showed that injection of conditioned medium obtained from MSC culture exerted cytoprotective effects on the myocardium (25).”
BackgroundEffects of mesenchymal stem cells on matrix metalloproteinase synthesis in cardiac fibroblasts
Wang, Y., Hu, X., Xie, X., He, A., Liu, X., & Wang, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010317 · Cited by 26
Wang, X., Li, Q., Hu, Q., Suntharalingam, P., From, A. H. L., & Zhang, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095247 · Cited by 24
Kearney, C., Khatab, S., van Buul, G. M., Plomp, S. G. M., Korthagen, N. M., Labberté, M. C., Goodrich, L. R., Kisiday, J. D., van Weeren, P. R., van Osch, G. J. V. M., et al. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.907616 · Cited by 24
An, Z., Tian, J., Liu, Y., Zhao, X., Yang, X., Yong, J., Liu, L., Zhang, L., Jiang, W., Song, X., et al. (2022) · Aging and Disease · doi:10.14336/ad.2022.0416 · Cited by 25
“Exosome therapy is now a possible alternative to cell therapy for the treatment of MI[101] .”
BackgroundSelf-citationGeng, Z., Guo, H., Li, Y., Liu, Y., & Zhao, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1090997 · Cited by 25
Mesenchymal Stromal Cell Phenotype is not Influenced by Confluence during Culture Expansion
Haack‐Sørensen, M., Hansen, S. K., Hansen, L. S., Gaster, M., Hyttel, P., Ekblond, A., & Kastrup, J. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9386-3 · Cited by 28
“MSCs secrete large quantities of bioactive molecules, such as growth factors, cytokines, antioxidants and mitogenic factors [13, 50].”
BackgroundVilas‐Boas, F., Feitosa, G. S., Soares, M. B. P., Pinho-Filho, J. A., Mota, A. C. A., Almeida, A. J. G., de Andrade, M. V. M., de CARVALHO, H. G., Oliveira, A. D., & Ribeiro‐dos‐Santos, R. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000028 · Cited by 24
REPAIR-AMI: Stem Cells for Acute Myocardial Infarction
Mills, J. S., & Rao, S. V. (2007) · Future Cardiology · doi:10.2217/14796678.3.2.137 · Cited by 24
Medhekar, S. K., Shende, V. S., & Chincholkar, A. B. (2016) · International Journal of Stem Cells · doi:10.15283/ijsc.2016.9.1.21 · Cited by 24
“jured tissue through wound healing (53-61).”
El-Husseini, F., M-AAA, S., Anber, N. H., Elghannam, D. M., M-A, S., Alsayed, A., Eldusoky, S., Sheashaa, H., Abdel-Ghaffar, H., & Sobh, M. A. K. (2016) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1201006 · Cited by 29
Therapeutic applications of adipose-derived stem cells in cardiovascular disease.
Bruun, K., Schermer, E., Sivendra, A., Valaik, E., Wise, R. B., Said, R., & Bracht, J. R. (2018) · Europe PMC (PubMed Central) · Cited by 24
Zhou, P., Liu, H., Liu, X., Ling, X., Xiao, Z., Zhu, P., Zhu, Y., Lu, J., & Zheng, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02114-7 · Cited by 24
Deng, W., Hilaire, R. S., Chattergoon, N. N., Jeter, J. R., & Kadowitz, P. J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.08.042 · Cited by 24
Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease
Radošinská, J., & Barteková, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_15 · Cited by 25
Stem Cell Differentiation: Cardiac Repair
Rubart, M., & Field, L. J. (2007) · Cells Tissues Organs · doi:10.1159/000112846 · Cited by 24
“Studies from the Dzau laboratory characterizing the basis of mesenchymal stem cell-mediated cardioprotection [Mangi et al., 2003; Gnecchi et al., 2005, 2006; Noiseux et al., 2006; Mirotsou et al., 2007] are exemplary.”
BackgroundPotential of Dental Pulp Stem Cell Exosomes: Unveiling miRNA-Driven Regenerative Mechanisms
Chansaenroj, J., Kornsuthisopon, C., Chansaenroj, A., Samaranayake, L. P., Fan, Y., & Osathanon, T. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.08.019 · Cited by 23
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.